Molecular and immune targets in cutaneous squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular and immune targets in cutaneous squamous cell carcinoma

Published:2022-08-24 Issue:1 Volume:62 Page:38-51
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Molecular Carcinogenesis

Author:

Galambus Justine¹^ORCID,Tsai Kenneth Y.²³⁴

Affiliation:

1. Morsani College of Medicine University of South Florida Tampa Florida USA

2. Department of Tumor Biology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

3. Department of Anatomic Pathology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

4. Donald A. Adam Melanoma and Skin Cancer Center of Excellence H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23451

Reference141 articles.

1. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022

2. The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma

3. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

4. Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22

5. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review;Translational Cancer Research;2024-06

2. MicroRNA-124 plays an inhibitory role in cutaneous squamous cell carcinoma cells via targeting SNAI2, an immunotherapy determinant;Heliyon;2024-02

3. MOLECULAR TARGETED THERAPIES FOR CUTANEOUS SQUAMOUS CELL CARCINOMA: RECENT DEVELOPMENTS AND CLINICAL IMPLICATIONS;EXCLI J;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3